P-wave duration on electrocardiography may serve as a surrogate marker of atrial remodeling to predict recurrence after atrial fibrillation ablation.
Does P-wave duration predict recurrence after ablation in patients with atrial fibrillation?
P-wave duration on ECG may serve as a valuable, cost-effective surrogate marker for atrial remodeling to predict recurrence after atrial fibrillation ablation.
Ablation of atrial fibrillation is one of the most widely applied invasive procedures in cardiovascular medicine, and populations with atrial fibrillation continuously rise. Recurrence rates are, however, consistently high, even in patients without severe comorbidities. Robust stratification algorithms to distinguish patients suitable for ablation are generally lacking. This is a fact caused by the inability to incorporate evidence of atrial remodeling and fibrosis, e.g., atrial remodeling, in the decision pathways. Cardiac magnetic resonance is a powerful tool in identifying fibrosis; however, it is costly and not routinely used. Electrocardiography has been generally underutilized in clinical practice during pre-ablative screening. One of the characteristics of the electrocardiogram that can give us valuable data depicting the existence and the extent of atrial remodeling and fibrosis is the duration of the P-wave. Currently, many studies support the implementation of P-wave duration in the routine practice of patient evaluation as a surrogate marker of existing atrial remodeling, that in turn predicts recurrence after ablation of atrial fibrillation. Further research is guaranteed to establish this electrocardiographic characteristic in our stratification quiver.
Koutalas et al. (Tue,) conducted a review in Atrial fibrillation. P-wave duration was evaluated on Recurrence after ablation of atrial fibrillation. P-wave duration on electrocardiography may serve as a surrogate marker of atrial remodeling to predict recurrence after atrial fibrillation ablation.